Presented at the ESHRE annual meeting, research from Paris identifies distinct alterations of gut microbiota and amino acid metabolism associated with increased miscarriage risk in women suffering from polycystic ovary syndrome (PCOS). This pioneering study elucidates possible metabolic pathways underlying reproductive challenges in PCOS, informing future therapeutic and microbiome-targeted interventions.